The State of Technology in Real-World Data in 2022 - A Panel Discussion
Real-world data (RWD) is no longer a buzzword or something from the future. With the 21st Century Cures act putting RWD in focus, and FDA guidance issued in January 2022 on its use in regulatory decision making, all functions within healthcare and life sciences need to understand the what, how, and when to use RWD for drug discovery, clinical development, and commercial use cases.
At the same time, technology has advanced both in how data are collected and harmonized and in how data are delivered and ingested by data subscribers. In this panel discussion thought leaders from Prognos, Qiagen, TriNetX, and AWS will discuss the RWD landscape in 2022 including how data are being collected and harmonized in a secure and privacy enabled way, top use cases being seen in biopharma, and how technology will play a role in RWD over the next 5 years.